This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Anti-Malarial drugs Market

Market Insights on Anti-Malarial drugs covering sales outlook, demand forecast & up-to-date key trends

Anti-Malarial drugs Market: Global Industry Analysis 2012 - 2016 and Opportunity Assessment; 2017 - 2027

Anti-Malarial drugs Market Overview

Anti-malarial drugs are the medicines used to prevent and treat malaria. The malaria is the disease caused due to the parasite known as Plasmodium, belongs to the organism group Protozoa. The malaria disease occurred in the tropical, subtropical and temperate regions of the world. Around 3.3 Billion people as half of the world’s population are at a risk of contracting malaria.

Every year near about 250 million malaria cases leads to the death of 1 million globally. The anti-malarial drugs are work in the treatment of malaria in individuals, prevention of infection in individuals and conventional intermittent treatment in the specific group in most prevalence endemic regions. Generally, malaria is treated by the single drug therapy as a first line therapy, and sometimes the combination drug therapy is for the second line of infection.

Anti-malarial drugs are available in the market in the form of tablet, injectables, and capsules.

Malaria is considered as a most dreadful disease as it causes of death due to limited availability of the anti-malarial drugs which has become the opportunity for the growth of the anti-malarial drugs market over a forecast period.

The global anti-malarial drugs market is anticipated to register a significant CAGR over a forecast period. The increasing prevalence of the malarial disease globally is expected to boost the demand of the anti-malarial drugs and drives the global anti-malarial drugs market. The increasing research and development activities for the new drugs and new combinations of drugs due to resistance by the parasites to the currently available drugs, also anticipated to drives the global anti-malarial drugs market.

The strong initiatives taken by the various state governments and regulatory bodies such as U.S. Food and Drug Administration (FDA) to reduce the prevalence of malarial disease throughout the world, also expected to fuel the demand for the anti-malarial drugs and has become the one of the factor drives the global anti-malarial drugs market over a forecast period.

However, the possible side effects of the anti-malarial drugs such as insomnia, vivid dreams, mental clouding, dizziness, and anxiety may hamper the demand for the anti-Malarial drug and restrain the growth of the global anti-malarial drugs market.

The availability of pure quality of drugs in the Southeast Asia and Saharan African countries leads to the inadequate treatment, which may pose a threat to the demand of the anti-malarial drugs and restrain the growth of the global anti-malarial drugs market over a forecast period.

On the basis of regional presence, the global anti-malarial drugs market is segmented into seven key regions: North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan, and Middle East & Africa. Currently, North America is contributing the leading shares to the global anti-malarial drugs market in terms of value and anticipated to register a significant CAGR over a forecast period.

The Europe is also contributing the moderate shares to the market due to the advanced medical facilities and availability of the anti-malarial drugs in the market. APAC is the most lucrative market for the anti-malarial drugs due to the highest prevalence of the malarial diseases in the region and expected to show a robust growth to the global anti-malarial drugs market.

MEA is at a nascent stage to the global anti-malarial drugs market and anticipated to register a decent growth to the market over a forecast period. Overall, the global anti-malarial drugs market is expected to show significant growth over a forecast period.

Customize this Report

Let us know your requirement to get
100% FREE customization

Market Players

Some of the major market players in anti-malarial drugs market globally include Pfizer, GlaxoSmithKline Plc., Ranbaxy Laboratories, Ipca Laboratories Ltd., Zydus Cadila, Merck KGaA, Novartis AG, Alvizia Health Care, Bayer AG and Roche Inc.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

The report covers exhaustive analysis on

  • Anti-malarial drugs market segments
  • Anti-malarial drugs market dynamics
  • Historical actual market size, 2014 - 2016
  • Anti-malarial drugs market size & forecast 2017 to 2027
  • Anti-malarial drugs current trends/issues/challenges
  • Competition & companies involved
  • Anti-malarial drugs market drivers and restraints

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil and Rest of Latin America)
  • Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg and Rest of Western Europe)
  • Eastern Europe (Poland, Russia and Rest of Eastern Europe)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC, S. Africa, and Rest of MEA)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.

The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Anti Malarial Drugs MarketThe global anti-malarial drugs market is segmented

on the basis of product type, solution delivery type, solution type and end user.

On the basis of malaria type, the global anti-malarial drugs market is segmented into:

  • Plasmodium Falciparum
  • Plasmodium Vivax
  • Plasmodium Malariae
  • Plasmodium Ovale

On the basis of drug type, the global anti-malarial drugs market is segmented into:

  • Quinine
  • Chloroquine
  • Amodiaquine
  • Pyrimethamine
  • Proguanil
  • Sulfonamide
  • Mefloquine
  • Atovaquone
  • Primaquine
  • Artemisinin and derivatives
  • Halofantrine
  • Doxycycline
  • Clindamycin

On the basis of distribution channel, the global anti-malarial drugs market is segmented into:

  • Hospital Pharmacy
  • Retail Pharmacy
  • E- Commerce
  • Others

On the basis of application, the global anti-malarial drugs market is segmented into:

  • Resistance
  • prevention

Table of Content

NA

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

NA

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

NA

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Anti-Malarial drugs Market